EUVIMEDEUVIMED entdecken
Crossref

Clinico-Pathological and Prognostic Significance of a Combination of Tumor Biomarkers in Iranian Patients With Breast Cancer

Masoud Hassanzadeh Makoui, Maryam Mobini, Shiva Fekri, Lobat Geranpayeh, Hedieh Moradi Tabriz, Zahra Madjd, Elham Kalantari, Maryam Hosseini, Mostafa Hosseini, Forough Golsaz-Shirazi, Mahmood Jeddi-Tehrani, Amir-Hassan Zarnani und 2 weitere

Clinical Breast Cancer · 2024

DOI: 10.1016/j.clbc.2023.09.013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Breast Cancer, 2024. Verfasst von Masoud Hassanzadeh Makoui und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Tehran University of Medical Sciences and Health Services.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsHumansFemaleBiomarkers, TumorPrognosisIranErb-b2 Receptor Tyrosine KinasesKi-67 AntigenLymphatic MetastasisTumor Suppressor Protein p53Receptors, Progesterone

Stichwörter der Autor:innen

Cancer diagnosisImmunohistochemistryTissue microarray

Substanzen

Biomarkers, TumorErb-b2 Receptor Tyrosine KinasesKi-67 AntigenTumor Suppressor Protein p53Receptors, Progesterone

Autor:innen und Institutionen

  • Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
  • Department of Gynecology and Obstetrics, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.
  • Department of Surgery, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran.
  • Department of Pathology, Tehran University of Medical Sciences, Tehran, Iran.
  • Oncopathology Research Center, Iran University of Medical Sciences, Tehran, Iran.
  • Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.

Förderung

  • Tehran University of Medical Sciences and Health Services

Zitieren

APA

Hassanzadeh Makoui, M., Mobini, M., Fekri, S., Geranpayeh, L., Moradi Tabriz, H., Madjd, Z., Kalantari, E., Hosseini, M., Hosseini, M., Golsaz-Shirazi, F., Jeddi-Tehrani, M., Zarnani, A. H., Amiri, M. M., & Shokri, F. (2024). Clinico-Pathological and Prognostic Significance of a Combination of Tumor Biomarkers in Iranian Patients With Breast Cancer. Clinical Breast Cancer. https://doi.org/10.1016/j.clbc.2023.09.013

Vancouver

Hassanzadeh Makoui M, Mobini M, Fekri S, Geranpayeh L, Moradi Tabriz H, Madjd Z, et al. Clinico-Pathological and Prognostic Significance of a Combination of Tumor Biomarkers in Iranian Patients With Breast Cancer. Clinical Breast Cancer. 2024. doi:10.1016/j.clbc.2023.09.013

BibTeX
@article{HassanzadehMakoui2024,
  author = {Hassanzadeh Makoui, Masoud and Mobini, Maryam and Fekri, Shiva and Geranpayeh, Lobat and Moradi Tabriz, Hedieh and Madjd, Zahra and Kalantari, Elham and Hosseini, Maryam and Hosseini, Mostafa and Golsaz-Shirazi, Forough and Jeddi-Tehrani, Mahmood and Zarnani, Amir-Hassan and Amiri, Mohammad Mehdi and Shokri, Fazel},
  title = {Clinico-Pathological and Prognostic Significance of a Combination of Tumor Biomarkers in Iranian Patients With Breast Cancer},
  journal = {Clinical Breast Cancer},
  year = {2024},
  doi = {10.1016/j.clbc.2023.09.013}
}
Kostenlos starten →